Copan Group

White Paper

Easing laboratory workflow in the pandemic

November 4, 2022

Microbiology and virology research have been boosted by Covid-19, as laboratories worldwide work tirelessly to develop diagnostic assays and therapies at an unprecedented pace. Preanalytics – the first step of the diagnostic path – obtained the same attention, as contact tracing and diagnosis rely on fast and accurate sample collection and handling. Mario Savarese, CEO of Copan WASP, explains how the company took advantage of its innovative thinking to support laboratories under pressure in the pandemic.

Download to find out more.